ERBB2 and gastric adenocarcinoma: Pathological studies showed a poorly differentiated gastric adenocarcinoma with a loss of nuclear expression of MLH1 and PMS2, a combined positive score (CPS) of 100, and immunochemistry for HER2 negative.